TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Solicited injection site (local) and systemic reactions for 7 days post-vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Medically attended adverse events (MAAEs), serious adverse events (SAEs), and adverse events of special interest (AESIs) for the entire study duration
Endpoint domain: Adverse events/effects
Primary endpoint: Type 1:3 collagen ratio reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-10 levels increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of successful use and application of Obsidian
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in adsorbance (A) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in patient's perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lower percent of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Shorter time of hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Editing efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Pain Interference
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of Participants Retained in buprenorphine Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevalence of preoperative iron deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of AI-assisted cEEG diagnostic tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change in pain levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Inflammatory and Non inflammatory Lesion count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of Adverse Sedation-Related Events in Musculoskeletal System
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Adverse Effect Related to Gastrointestinal Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Side effects of nasal photodisinfection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in duration sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Composite End-point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with nonfatal ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants with nonfatal myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants with vascular death including sudden death
Endpoint domain: Mortality/survival
Primary endpoint: ratio of slow wave sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: ratio of rem sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Change in Leg press strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Group differences in Patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite endpoint of all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Hospitalization for unstable angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ventilatory flow per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sexuality anomalies score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of locoregional anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percent area change after 4 weeks of treatment compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence in wound closure by week 12 of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-HPV type specific antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: spectrum and natural history of lymphoproliferative disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: failure rate of UAS insertion
Endpoint domain: Adverse events/effects
Primary endpoint: Willingness to Try Hookah Tobacco
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to Smoke Hookah Tobacco
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of brain images analysed for sodium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum flow rate of the urine after the procedure (Qmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: international prostate symptoms score (IPSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: post voiding residual urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Eradication of disease
Endpoint domain: Mortality/survival
Primary endpoint: Change in scores on the Generalized Anxiety Disorder 7-item scale (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in scores on the Patient Health Questionnaire-9 (PHQ-9)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in scores on the Perceived Stress Scale (PSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in scores on the World Health Organization Well-Being Index (WHO-5)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acceptability measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of Retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Isometric Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of wound area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 5day_AUC0-τ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall prevalence of uric acid stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Body part discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Efficacy in Clinical Performance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IBS-QoL index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Relationship satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Positive Communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in Negative Communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Well-being Inventory - Functional Status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Concentration-time curve in plasma glucose (AUC(0-120min))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in brain insulin resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time-to-decompensation
Endpoint domain: Mortality/survival
Primary endpoint: Toronto Upper Gastrointestinal Cleaning Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Need for second look endoscopy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Use of inhaler devices
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Plasma levels of heparan-sulphate and syndecan-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ongoing pregnancy or live birth rate
Endpoint domain: Mortality/survival
Primary endpoint: Resolution of Trigger Finger Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Environmental stressors perceived by patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bone flap planarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Hospital Anxiety and Depression Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fNIRS based measures of touch processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ratings of the pleasantness, arousal, intensity and payment for the applied social touch
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SARS COV 2 Viral clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: World Health Organization COVID-19 ordinal improvement score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fonseca Anamnestic Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Initiation of effective TB drugs within 14 days of diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VAS pain score at 24 hours post-procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fasting Glucagon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma Concentration of ripretinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of DP-5439
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New Lower Urinary Tract Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Positive diagnosis of SSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of CV death, new MI, or IDR
Endpoint domain: Mortality/survival
Primary endpoint: Time to first occurrence of clinically significant bleeding, stroke, stent thrombosis, or contrast-associated acute kidney injury
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in pain after a hepatic hilar nerve block during and immediately after liver ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in narcotic use after a hepatic hilar nerve block during and immediately after liver ablation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: National Eye Index Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of oncodriver status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 30 days severe morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-6 concentration in synovial fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prognosis of SAKI patients
Endpoint domain: Mortality/survival
Primary endpoint: T-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and joint outcomes
Primary endpoint: Aortic calcification index (ACI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Beta-Stiffness Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Child perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child emotional distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child positive affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NDI for disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Lateral cervical radiograph for Cobb's angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal Comfort Behavior Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fugl-Meyer Assessment for upper extremity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change in Stroke Impact Scale score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Motricity Index of the Arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Intent to vaccinate against COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in cerebral circulation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With at Least One Device-related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: long-term outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in cardiac output level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Baseline in explosive strength of lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in body mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Risk of Recurrent Colorectal Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Net clinical adverse event (NACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Major adverse cardiac and cerebrovascular event (MACCE)
Endpoint domain: Adverse events/effects
Primary endpoint: Major bleeding (BARC type 3,5)
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence of bacterial vaginosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MRI abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shigella incidence
Endpoint domain: Adverse events/effects
Primary endpoint: NFL chain levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Response rate by CA-125
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PROMIS-anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in PROMIS-depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants continuing treatment without interruptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanical axis of lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee injury and Osteoarthritis outcome score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants with a treatment-limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with an AE or SAE attributed to HBO therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Total scoring of MMSE
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total scoring of MMS-RUN
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: P300 Amplitude during Erickson Flanker Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Global Assessment of Functioning (GAF) Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adult ADHD Self-Report Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Infections or Rejections
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Peak Pruritus Numerical Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improved global rating of change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of the five most prevalent STIs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of different barrier methods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use of barrier methods in sexual intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoxic index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of conjugated hyperbilirubinemia >3 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: screen attention time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of repetitions of the exercises
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global scores for exercise
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Therapeutic response to antihistamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in functional outcome (qDASH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in pain (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mPAP/CO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mPAP/CO slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global longitudinal strain (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: expression of TLR2/TRL4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Nodule Detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improving stress management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Protein level of molecular biomarkers in nasal epithelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mRNA level of inflammation molecular biomarkers in nasal epithelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Level of inflammation molecular biomarkers in nasal lavage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of infants with infectious morbidity from 4-24 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: Infant length for age Z scores (LAZ) from 4-24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of infants with infectious morbidity from 4-48 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: Infant length for age Z scores (LAZ) from 4-48 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in glutamate concentration in the medial prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ventilatory efficiency M0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ventilatory efficiency M6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: scale of dental anxiety by Corah Dental Anxiety Scale (CDAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: scale of dental anxiety by Facial Image Scale (FIS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: scale of dental anxiety by Venham Clinical Anxiety Scale (VCAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Falls with injury
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in size and extent of corneal neovascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Degree of consensus on the curriculum
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Changes of heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in chest electrical impedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in affective responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in subjective perception of stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitude towards CPR
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child Dietary Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child Neck Circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for Aluminum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for Aluminum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for Magnesium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes